Bullous Pemphigoid Associated with Dipeptidyl Peptidase 4 Inhibitors for the Treatment of Type 2 Diabetes: A Multicenter Study in Istanbul

OBJECTIVES: Recent studies have revealed an association between dipeptidyl peptidase 4 inhibitors (DPP4i) and development of bullous pemphigoid (BP). The main aim of our study is to evaluate the association between DPP4i treatment and BP development. The secondary endpoints were to evaluate clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Ugurer, Ece, Ozkur, Ezgi, Altunay, Ilknur Kivanc, Sen, Esra Cil, Aksu, Ayse Esra Koku, Ozcan, Ilknur, Altuntas, Yuksel, Gurel, Mehmet Salih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Med Bull Sisli Etfal Hosp 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580981/
https://www.ncbi.nlm.nih.gov/pubmed/36304224
http://dx.doi.org/10.14744/SEMB.2022.30111

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580981/
https://www.ncbi.nlm.nih.gov/pubmed/36304224
http://dx.doi.org/10.14744/SEMB.2022.30111

Ejemplares similares